As a result, we hypothesized that applying autophagy activators to CDCA4 high expression patients could reverse EMT and significantly prevent NSCLC cell invasion due to its enhanced anti-invasive effect. The gene discussed is CDCA4; the disease is non-small cell lung carcinoma.